BRIEF published on 07/16/2025 at 08:05, 1 year 3 months ago GeNeuro SA announces the liquidation of its French subsidiary Restructuring Liquidation GeNeuro Subsidiary Neurodegenerative
PRESS RELEASE published on 07/16/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases GeNeuro SA announces the liquidation of its French subsidiary GeNeuro Innovation SAS, part of the restructuring process. Court appointed liquidator SELARL MJ-Synergie Liquidation Restructuring Process GeNeuro SA GeNeuro Innovation SAS SELARL MJ-Synergie
BRIEF published on 06/30/2025 at 19:42, 1 year 4 months ago GeNeuro's Shareholders Approve All Resolutions at Extraordinary General Meeting Shareholder Approval Restructuring Extraordinary General Meeting GeNeuro Asset Monetization
PRESS RELEASE published on 06/30/2025 at 19:37, 1 year 4 months ago Inside Information / Other news releases GeNeuro announces approval of all resolutions proposed at Extraordinary General Meeting with 69.1% share capital representation. Jesús Martin-Garcia named Executive Chairman Shareholders EGM Resolutions GeNeuro Jesús Martin-Garcia
BRIEF published on 06/12/2025 at 22:47, 1 year 4 months ago GeNeuro SA: Judicial recovery for its French subsidiary Restructuring GeNeuro SA Judicial Recovery French Subsidiary Judicial Administrator
PRESS RELEASE published on 06/12/2025 at 22:42, 1 year 4 months ago Inside Information / Other news releases GeNeuro SA's French subsidiary GeNeuro Innovation SAS enters receivership proceedings amidst parent company's debt-restructuring efforts Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Receivership Proceedings
BRIEF published on 12/13/2024 at 12:02, 1 year 10 months ago Citigroup reduces its stake in GENEURO SA Euronext Paris Sale Of Shares Threshold Crossing GeNeuro SA Citigroup
BRIEF published on 12/06/2024 at 18:35, 1 year 10 months ago GeNeuro's New Precision Medicine for ALS Unveiled Precision Medicine GeNeuro ALS Treatment GNK-301 HERV-K ENV
PRESS RELEASE published on 12/06/2024 at 18:30, 1 year 10 months ago Inside Information / Other news releases GeNeuro presents groundbreaking findings on precision medicine for ALS patients with GNK-301 at the 35th International Symposium on ALS/MND. Research highlights potential of targeting HERV-K ENV to transform ALS treatment Precision Medicine ALS GeNeuro GNK-301 HERV-K ENV
BRIEF published on 11/06/2024 at 09:48, 1 year 11 months ago Crossing of thresholds by Invus Public Equities in GENEURO SA Euronext Paris Capital Increase Crossing Thresholds GeNeuro SA Invus Public Equities
Published on 11/06/2026 at 05:15, 1 hour 38 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 6 hours ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 6 hours 8 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:20, 7 hours 33 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 06:45, 8 minutes ago Krones reports moderate growth and improved profitability in a challenging market environment
Published on 11/06/2026 at 04:55, 1 hour 57 minutes ago Segway Powersports Strengthens European Dealer Partnerships at EICMA 2026
Published on 11/06/2026 at 04:15, 2 hours 38 minutes ago Geely’s i-HEV Intelligent Hybrid Technology Offers a New Direction Vision for Gasoline-Powered Vehicles
Published on 11/06/2026 at 03:55, 2 hours 57 minutes ago Coway Announces Financial Results for Q3 FY2026
Published on 11/05/2026 at 18:21, 12 hours 31 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 13 hours 8 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 13 hours 23 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
Published on 11/05/2026 at 10:16, 20 hours 36 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
